Your browser doesn't support javascript.
loading
Current directions in tau research: Highlights from Tau 2020.
Sexton, Claire; Snyder, Heather; Beher, Dirk; Boxer, Adam L; Brannelly, Pat; Brion, Jean-Pierre; Buée, Luc; Cacace, Angela M; Chételat, Gaël; Citron, Martin; DeVos, Sarah L; Diaz, Kristophe; Feldman, Howard H; Frost, Bess; Goate, Alison M; Gold, Michael; Hyman, Bradley; Johnson, Keith; Karch, Celeste M; Kerwin, Diana R; Koroshetz, Walter J; Litvan, Irene; Morris, Huw R; Mummery, Catherine J; Mutamba, James; Patterson, Marc C; Quiroz, Yakeel T; Rabinovici, Gil D; Rommel, Amy; Shulman, Melanie B; Toledo-Sherman, Leticia M; Weninger, Stacie; Wildsmith, Kristin R; Worley, Susan L; Carrillo, Maria C.
Afiliação
  • Sexton C; Alzheimer's Association, Chicago, Illinois, USA.
  • Snyder H; Alzheimer's Association, Chicago, Illinois, USA.
  • Beher D; Asceneuron, Lausanne, Switzerland.
  • Boxer AL; Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, California, USA.
  • Brannelly P; Alzheimer's Disease Data Initiative, Kirkland, WI, USA.
  • Brion JP; Laboratory of Histology, Neuroanatomy and Neuropathology, Faculty of Medicine, Université Libre de Bruxelles, Brussels, Belgium.
  • Buée L; Univ Lille, Inserm, CHU-Lille, Lille Neuroscience and Cognition, Place de Verdun, Lille, France.
  • Cacace AM; Neuroscience and Platform Biology, Arvinas, New Haven, USA.
  • Chételat G; Normandie Univ, UNICAEN, INSERM, U1237, PhIND "Physiopathology and Imaging of Neurological Disorders", Institut Blood and Brain @ Caen-Normandie, Cyceron, Caen, France.
  • Citron M; Neuroscience TA, Braine l'Alleud, UCB Biopharma, Brussels, Belgium.
  • DeVos SL; Translational Sciences, Denali Therapeutics, San Francisco, California, USA.
  • Diaz K; Cure PSP, New York, New York, USA.
  • Feldman HH; Alzheimer's Disease Cooperative Study, Department of Neurosciences, University of California, San Diego, La Jolla, California, USA.
  • Frost B; Sam & Ann Barshop Institute for Longevity and Aging Studies, Glenn Biggs Institute for Alzheimer's & Neurodegenerative Disorders, Department of Cell Systems & Anatomy, University of Texas Health San Antonio, San Antonio, Texas, USA.
  • Goate AM; Ronald M. Loeb Center for Alzheimer's Disease, Department of Neuroscience, Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Gold M; AbbVie, Neurosciences Development, North Chicago, Illinois, USA.
  • Hyman B; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Johnson K; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Karch CM; Department of Psychiatry, Washington University in St. Louis, St. Louis, Missouri, USA.
  • Kerwin DR; Kerwin Medical Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Koroshetz WJ; National Institute of Neurological Disorders and Stroke, Bethesda, Maryland, USA.
  • Litvan I; Parkinson and Other Movement Disorders Center, Department of Neurosciences, University of California San Diego, San Diego, California, USA.
  • Morris HR; Department of Clinical and Movement Neuroscience, UCL Queen Square Institute of Neurology, London, UK.
  • Mummery CJ; Dementia Research Centre, National Hospital for Neurology and Neurosurgery, University College London, London, UK.
  • Mutamba J; Longwood Fund, Boston, Massachusetts, USA.
  • Patterson MC; Departments of Neurology, Pediatrics and Medical Genetics, Mayo Clinic, Rochester, Minnesota, USA.
  • Quiroz YT; Departments of Neurology and Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Rabinovici GD; Memory & Aging Center, Departments of Neurology, Radiology & Biomedical Imaging, University of California San Francisco, San Francisco, California, USA.
  • Rommel A; Tau Consortium, Rainwater Charitable Foundation, Fort Worth, Texas, USA.
  • Shulman MB; Neurodegeneration Development Unit, Biogen, Boston, Massachusetts, USA.
  • Toledo-Sherman LM; Tau Consortium, Rainwater Charitable Foundation, Fort Worth, Texas, USA.
  • Weninger S; FBRI, Cambridge, Massachusetts, USA.
  • Wildsmith KR; Department of Biomarker Development, Genentech, South San Francisco, California, USA.
  • Worley SL; Independent science writer, Bryn Mawr, Pennsylvania, USA.
  • Carrillo MC; Alzheimer's Association, Chicago, Illinois, USA.
Alzheimers Dement ; 18(5): 988-1007, 2022 05.
Article em En | MEDLINE | ID: mdl-34581500
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Alzheimer / Disfunção Cognitiva Limite: Humans Idioma: En Revista: Alzheimers Dement Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Alzheimer / Disfunção Cognitiva Limite: Humans Idioma: En Revista: Alzheimers Dement Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos